Concepedia

Ryan Sobel

RS

Statistics

Publications

7

Citations

480

H-Index

7

Active since

2017

Affiliations

Wayne State University(Current)

Thomas Jefferson University

Case Western Reserve University

Scynexis (United States)

Drexel University

Ryan Sobel is an author at Wayne State University specializing in vulvovaginal disorders, antimicrobial pharmacotherapy, and vulvovaginal candidiasis treatment.

ORCID

Publications per year

2017–2023

7

Publications

7

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

Junko Yano, Jack D. Sobel, Paul Nyirjesy et al. · BMC Women s Health · 2019 · 264 citations · Full text

, , +12

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)

Jane R. Schwebke, Ryan Sobel, Janet Gersten et al. · Clinical Infectious Diseases · 2021 · 76 citations · Full text

, , +17

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)

Ryan Sobel, Paul Nyirjesy, MA Ghannoum et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2021 · 52 citations · Full text

, , +13

Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers

Steven Chavoustie, Scott Evan Eder, William Koltun et al. · International Journal of Gynecology & Obstetrics · 2017 · 25 citations · Full text

, , +17

Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306

Oluwatosin Goje, Ryan Sobel, Paul Nyirjesy et al. · Journal of Women s Health · 2022 · 23 citations · Full text

, , +17

1–5 of 7